D. E. Shaw & Co., Inc. Synlogic, Inc. Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.0 - $4.39 $42,501 - $62,193	-14,167 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.2 - $5.05 $379,583 - $871,316	-172,538 Reduced 92.41%	14,167 $51,000
Q4 2020 Feb 16, 2021	BUY	$1.85 - $2.54 $85,915 - $117,960	46,441 Added 33.11%	186,705 $403,000
Q3 2020 Nov 16, 2020	SELL	$1.85 - $2.57 $20,932 - $29,079	-11,315 Reduced 7.46%	140,264 $283,000
Q2 2020 Aug 14, 2020	BUY	$1.59 - $2.51 $213,624 - $337,231	134,355 Added 780.05%	151,579 $308,000
Q1 2020 May 15, 2020	SELL	$1.39 - $3.19 $125,304 - $287,568	-90,147 Reduced 83.96%	17,224 $30,000
Q4 2019 Feb 14, 2020	BUY	$1.96 - $2.81 $210,447 - $301,712	107,371 New	107,371 $277,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.